Effectiveness of the current and prior influenza vaccinations in Northern Spain, 2018-2019

被引:7
|
作者
Castilla, Jesus [1 ,2 ]
Eugenia Portillo, Maria [3 ]
Casado, Itziar [1 ,2 ]
Pozo, Francisco [2 ,4 ]
Navascues, Ana [3 ]
Adelantado, Marta [3 ]
Gomez Ibanez, Carlos [1 ]
Ezpeleta, Carmen [3 ]
Martinez-Baz, Ivan [1 ,2 ]
机构
[1] Inst Salud Publ Navarra IdiSNA, Pamplona, Spain
[2] CIBERESP, Madrid, Spain
[3] Complejo Hosp Navarra IdiSNA, Pamplona, Spain
[4] Inst Salud Carlos III, WHO Natl Influenza Ctr Madrid, Ctr Nacl Microbiol, Majadahonda, Spain
关键词
Influenza; Influenza vaccine; Influenza-like illness; Case-control study; Vaccine effectiveness; Repeated vaccination; VACCINE EFFECTIVENESS; SEASON PROTECTION; UNITED-STATES; VIRUS; CHILDREN; HEMAGGLUTININ; A(H3N2); ILLNESS; CANADA;
D O I
10.1016/j.vaccine.2020.01.028
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: The population targeted for influenza vaccination can be repeatedly vaccinated over successive seasons, and vaccines received in previous seasons may retain preventive effect. This study aims to estimate the effectiveness of inactivated influenza vaccines received in the current and prior seasons in the 2018-2019 season. Methods: Influenza-like illness patients attended by sentinel general practitioners or admitted to hospitals in Navarre, Spain, were tested for influenza. Vaccination status in the current and three prior seasons was obtained from the vaccination registry. The test-negative design was used to estimate the vaccine effectiveness. Results: A total of 381 influenza A(H1N1)pdm09 cases, 341 A(H3N2) cases and 1222 controls were analysed. As compared to individuals unvaccinated in the current and three prior seasons, the influenza vaccine effectiveness against A(H1N1)pdm09 was 57% (95% confidence interval ICI]: 40%, 70%) for current season vaccination regardless of prior doses and 48% (95%Cl: 14%, 68%) for vaccination in prior seasons but not in the current season. These estimates were 12% (95%CI: -23%, 37%) and 27% (95%CI: -22%, 56%), respectively, against influenza A(H3N2). Individuals vaccinated with the two A(H1N1)pdm09 strains in influenza vaccines since 2009, A/Michigan/45/2015 and A/California/07/2009, had higher protection (68%; 95%CI: 53%, 77%) than those vaccinated with A/Michigan/45/2015 only (29%, p = 0.020) or with A/California/07/2009 only (34%, p = 0.005). Conclusion: These results suggest moderate effectiveness of influenza vaccination against A(H1N1) pdm09 and low effectiveness against A(H3N2) influenza in the 2018-2019 season. Vaccination in prior seasons maintained a notable protective effect. Strains included in previous vaccines were as effective as the current vaccine strain, and both added their effects against influenza A(H1N1)pdm09. (C) 2020 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1925 / 1932
页数:8
相关论文
共 50 条
  • [31] Comparison of A(H3N2) Neutralizing Antibody Responses Elicited by 2018-2019 Season Quadrivalent Influenza Vaccines Derived from Eggs, Cells, and Recombinant Hemagglutinin
    Wang, Wei
    Alvarado-Facundo, Esmeralda
    Vassell, Russell
    Collins, Limone
    Colombo, Rhonda E.
    Ganesan, Anuradha
    Geaney, Casey
    Hrncir, David
    Lalani, Tahaniyat
    Markelz, Ana Elizabeth
    Maves, Ryan C.
    McClenathan, Bruce
    Mende, Katrin
    Richard, Stephanie A.
    Schofield, Christina
    Seshadri, Srihari
    Spooner, Christina
    Utz, Gregory C.
    Warkentien, Tyler E.
    Levine, Min
    Coles, Christian L.
    Burgess, Timothy H.
    Eichelberger, Maryna
    Weiss, Carol D.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (11) : E4312 - E4320
  • [32] Intensified epidemiological surveillance of arbovirosis: First case of native dengue fever in Catalonia (Spain), Northern Metropolitan Area of Barcelona, 2018-2019
    Valerio, Lluis
    Roure Diez, Silvia
    Benitez, Rosa
    Fernandez-Rivas, Gema
    Rivaya, Belen
    Exposito, Carme
    Saperas, Carme
    Salvador, Fernando
    Clotet, Bonaventura
    ATENCION PRIMARIA, 2021, 53 (01): : 73 - 80
  • [33] Evaluation of the 2018-2019 vaccine effectiveness against medically attended influenza-like illness using medical records and claims data
    Doyon-Plourde, Pamela
    Fortin, Elise
    Quach, Caroline
    VACCINE, 2022, 40 (39) : 5732 - 5738
  • [34] Retrospective screening for SARS-CoV-2 among influenza-like illness hospitalizations: 2018-2019 and 2019-2020 seasons, Valencia region, Spain
    Mira-Iglesias, Ainara
    Mengual-Chulia, Beatriz
    Cano, Laura
    Garcia-Rubio, Javier
    Tortajada-Girbes, Miguel
    Carballido-Fernandez, Mario
    Mollar-Maseres, Juan
    Schwarz-Chavarri, German
    Garcia-Esteban, Sandra
    Puig-Barbera, Joan
    Diez-Domingo, Javier
    Xavier Lopez-Labrador, F.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2022, 16 (01) : 166 - 171
  • [35] Knowledge, attitudes and uptake related to influenza vaccine among healthcare workers during the 2018-2019 influenza season in Tunisia
    Cherif, Ines
    Kharroubi, Ghassen
    Bouabid, Leila
    Gharbi, Adel
    Boukthir, Aicha
    Ben Alaya, Nissaf
    Ben Salah, Afif
    Bettaieb, Jihene
    BMC PUBLIC HEALTH, 2021, 21 (01)
  • [36] ETIOLOGY OF INFLUENZA-LIKE ILLNESSES IN THE POPULATION OF NOVOSIBIRSK CITY IN THE 2018-2019 EPIDEMIC SEASON
    Kurskaya, O. G.
    Anoshina, A., V
    Leonova, N., V
    Simkina, O. A.
    Komissarova, T., V
    Esikova, E. Yu
    Pozdnyakova, L. L.
    Sobolev, I. A.
    Prokopyeva, E. A.
    Kazachkova, E. A.
    Danilenko, D. M.
    Komissarov, A. B.
    Stolyarov, K. A.
    Fadeev, A., V
    Sominina, A. A.
    Sharshov, K. A.
    Yu, Alekseev A.
    Shestopalov, A. M.
    Murashkina, T. A.
    INFEKTSIYA I IMMUNITET, 2021, 11 (04): : 723 - 736
  • [37] Detection of Variants With Reduced Baloxavir Marboxil Susceptibility After Treatment of Children With Influenza A During the 2018-2019 Influenza Season
    Sato, Masatoki
    Takashita, Emi
    Katayose, Masahiko
    Nemoto, Kenji
    Sakai, Nobuko
    Hashimoto, Koichi
    Hosoya, Mitsuaki
    JOURNAL OF INFECTIOUS DISEASES, 2020, 222 (01) : 121 - 125
  • [39] Neuraminidase characterisation reveals very low levels of antiviral resistance and the presence of mutations associated with reduced antibody effectiveness in the Irish influenza 2018/2019 season
    Brehony, Carina
    Dunford, Linda
    Bennett, Charlene
    O'Donnell, Joan
    Domegan, Lisa
    McNamara, Eleanor
    De Gascun, Cillian F.
    JOURNAL OF CLINICAL VIROLOGY, 2020, 132
  • [40] Seasonal influenza vaccine effectiveness among health-care workers in Prince Sultan Military Medical City, Riyadh, KSA, 2018-2019
    Al Qahtani, Abdulaziz A.
    Selim, Mohie
    Hamouda, Naglaa H.
    Al Delamy, Abdullah L.
    Macadangdang, Charmaine
    Al Shammari, Khalaf H.
    Al Shamary, Sahar F.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (01) : 119 - 123